<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05091268</url>
  </required_header>
  <id_info>
    <org_study_id>2019/28494(REK)</org_study_id>
    <nct_id>NCT05091268</nct_id>
  </id_info>
  <brief_title>Effect of Physical Activity and Pain Education on Endometriosis-associated Pain</brief_title>
  <official_title>Effect of Physical Activity and Pain Education on Endometriosis-associated Pain A Randomizes Controlled Trial With a Multimodal Interdisciplinary Group Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Akershus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fysiofondet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kristiania University College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Akershus</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endometriosis is a benign gynecological condition where the uterine endometrium is located&#xD;
      outside the uterus. The condition affects up to 10% of women of fertile age and up to 70% of&#xD;
      women with endometriosis have symptoms with severe pain during menstruation (dysmenorrhea),&#xD;
      pain during intercourse (dyspareunia), and/or chronic pelvic pain. Current treatments are&#xD;
      dictated by the primary symptom: pain and are limited to surgery and hormonal treatments with&#xD;
      often short-lived effects. Advances in the understanding of the condition have expanded to&#xD;
      focus on less invasive and non-pharmacological treatments. Systematic reviews and&#xD;
      meta-analyses of observational studies have focused on the protective role of physical&#xD;
      activity and exercise on the risk of developing endometriosis. The results from these studies&#xD;
      have been inconclusive. However, the efficacy of physical activity and exercise on pain among&#xD;
      women with endometriosis has not been tested in high-quality randomized controlled trials&#xD;
      (RCT).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Due to the complexity of the disease, international clinical guidelines recommend that the&#xD;
      treatment of endometriosis-associated pain should come from a multimodal and&#xD;
      multidisciplinary perspective. Numerous non-pharmacological treatments have been proposed to&#xD;
      alleviate endometriosis-associated pain, such as physical activity. Physical activity was&#xD;
      introduced as a factor in the treatment of endometriosis-associated pain over three decades&#xD;
      ago, with the possible beneficial effect that physical activity stimulates anti-inflammatory&#xD;
      properties that will impede the development of endometriosis and lower the pain. A recent&#xD;
      systematic review and meta-analysis found one randomized controlled study that showed no&#xD;
      effect of physical activity on endometriosis-associated pain. They concluded that the&#xD;
      methodological quality of this study was low, and the need for future randomized controlled&#xD;
      studies was warranted. We, therefore, aimed to study the effect of pain education and&#xD;
      group-based physical activity versus pain education alone on women with&#xD;
      endometriosis-associated pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">January 2026</completion_date>
  <primary_completion_date type="Anticipated">January 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endometriosis associated pain</measure>
    <time_frame>Measured at baseline and after 4 months and 12 months</time_frame>
    <description>Electronically patient-reported genito-pelvic pain will include a pain body map and pain intensity scale (NRS). We will ask for average pain, worst pain, and conditional pain over the course of one month.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of physical activity</measure>
    <time_frame>Measured at baseline and after 4 months and 12 months</time_frame>
    <description>Electronically patient-reported physical activity level will be measured using the International physical activity questionnaire-short form (IPAQ-SF).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic floor muscle maximal contraction and resting tension</measure>
    <time_frame>Measured at baseline and after 4 months</time_frame>
    <description>Pelvic floor muscle maximal contraction and muscular endurance will be measured with manometer using a vaginal balloon catheter Camtech Sandvika Norge AS (cmH2O) will be assessed. This method has demonstrated good validity and reliability, by our research group.&#xD;
Resting tension and the ability to contract using surface electromyography (EMG) will be used with a vaginal probe (Quintet). We will also perform vaginal palpation to assess pain/tenderness and tone. (All women will be instructed on how to correctly perform a pelvic floor muscle contraction prior to assessment).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function and sexual pain</measure>
    <time_frame>Measured at baseline and after 4 months and 12 months</time_frame>
    <description>Electronically patient-reported assessment using the Female Sexual Function Index (FSFI). We will also use questions adapted from Sahlgrenska University Hospital related to sexual pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression and anxiety</measure>
    <time_frame>Measured at baseline and after 4 months and 12 months</time_frame>
    <description>Electronically patient-reported assessment using Hopkins Symptom Check List (SCL-5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain with urination</measure>
    <time_frame>Measured at baseline and after 4 months and 12 months</time_frame>
    <description>Electronically patient-reported assessment of pain prior to, during or after urination (developed by urologists at Akershus University Hospital)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel function</measure>
    <time_frame>Measured at baseline and after 4 months and 12 months</time_frame>
    <description>Electronically patient-reported assessment of bowel function including pain and constipation using the Knowles-Eccersley-Scott-Symptom (KESS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economy and related quality of life</measure>
    <time_frame>Measured at baseline and after 4 months and 12 months</time_frame>
    <description>Electronically patient-reported assessment using health-related quality of life questionnaire (EQ5D)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Body mass index</measure>
    <time_frame>Measured at baseline</time_frame>
    <description>Weight and height will be combined to report BMI in kg/m^2. Weight will be measures wearing underwear and height will be measured against a wall wearing no shoes or heavy clothing.</description>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction and experience with physical activity and pain management</measure>
    <time_frame>Measured after 4 months</time_frame>
    <description>A qualitative interview with open ended questions to participants in both the intervention and control group that include satisfaction with participating and experience with physical exercise and pain management.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>Exercise group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will attend a four-hour pain education session including gynecologist, psychologist, sexologist, and physiotherapist at Akershus University Hospital.&#xD;
The education will be held twice, with half of the participants at the time. The training group will then attend a 60 minutes weekly group training session led by a physiotherapist with specialist training in women's health, over a period of four months. In addition, participants will perform a progressive home exercise program performed daily over the same period. The focus will be general strength training using own body weight and cardiovascular fitness (walking, low-impact aerobic exercise), stretching, and relaxation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pain education group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No further follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>All participants will attend a four-hour pain education session including gynecologist, psychologist, sexologist, and physiotherapist at Akershus University Hospital.&#xD;
The education will be held twice, with half of the participants at the time. The training group will then attend a 60 minutes weekly group training session led by a physiotherapist with specialist training in women's health over a period of four months. In addition, participants will perform a progressive home exercise program performed daily over the same period. The focus will be general strength training using own body weight and cardiovascular fitness (walking, low-impact aerobic exercise), stretching, and relaxation</description>
    <arm_group_label>Exercise group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women of age 18-45 with signs of endometriosis on ultrasound and/or MRI and/or&#xD;
             confirmed by laparoscopy with histology at Akershus University Hospital and Oslo&#xD;
             University Hospital. Women may also be recruited through social media but must present&#xD;
             with diagnosis of endometriosis.&#xD;
&#xD;
          -  genital-pelvic pain â‰¥4/10 as measured on a numeric rating scale.&#xD;
&#xD;
          -  able to understand and speak Norwegian language&#xD;
&#xD;
          -  able to meet at Akershus University Hospital for participation in the study&#xD;
&#xD;
          -  giving signed consent to participate.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intra-abdominal or vaginal surgery in the last six months&#xD;
&#xD;
          -  Patients who have received Botox over the past four months&#xD;
&#xD;
          -  Severe pathology (malignancy),cardiovascular conditions and immune system diseases&#xD;
             diagnosed by specialist; pregnancy, as well as childbirth the last 12 months and&#xD;
             breastfeeding; severe psychiatric disorders that demands or has demanded admission to&#xD;
             the hospital; personality disorder diagnosed by specialist and recently started or&#xD;
             recently adjusted ongoing hormonal therapy.&#xD;
&#xD;
          -  Participants should not have any disease or injury that could prevent them from&#xD;
             participating in the intervention.&#xD;
&#xD;
          -  Participants will be encouraged not to start with any new treatment&#xD;
             (non-pharmacological or pharmacological) during the four-month intervention period.&#xD;
&#xD;
          -  Participants who have recently undergone surgery and received Botox injections into&#xD;
             the pelvic area can be referred but must wait 4-6 months before being included in the&#xD;
             study. Women with planned surgery or Botox in the study period will be excluded.&#xD;
&#xD;
          -  Participants recently started or adjusting ongoing hormonal therapy must wait 3-6&#xD;
             months to be included in the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>The study is on endometriosis which only affect women in fertile age</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merete Kolberg Tennfjord, Phd</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Merete Kolberg Tennfjord, Phd</last_name>
    <phone>98663431</phone>
    <email>merete.kolberg@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rakel Gabrielsen, Ms</last_name>
    <phone>92677147</phone>
    <email>rakel.gabrielsen@gmail.com</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>October 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Akershus</investigator_affiliation>
    <investigator_full_name>Merete Kolberg Tennfjord</investigator_full_name>
    <investigator_title>Phd</investigator_title>
  </responsible_party>
  <keyword>endometriosis</keyword>
  <keyword>women's health</keyword>
  <keyword>pelvic floor</keyword>
  <keyword>physical activity</keyword>
  <keyword>pain education</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

